3Vote!
Business Wire (Free subscription) | yesterday
IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial stage biotechnology company with a primary focus in oncology, today announced that clinical data on ZEVALIN will be presented at the 51st Annual Meeting of the American Society of Hematology (ASH), being held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans,...
3Vote!
PR News Wire (Free subscription) | yesterday
NEW ORLEANS, Dec. 1 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional association of blood specialists, expects more than 20,000 attendees at the 51st ASH Annual Meeting from December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA. The meeting will showcase the latest research and treatments for blood...
3Vote!
PR News Wire (Free subscription) | yesterday
NEW ORLEANS, Dec. 1 /PRNewswire-USNewswire/ -- The American Society of Hematology (ASH), the world's largest professional association of blood specialists, expects more than 20,000 attendees at the 51st ASH Annual Meeting from December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA. The meeting will showcase the latest research and treatments for blood...
+Vote!
Business Wire (Free subscription) | yesterday
... be presented at the 51st Annual Meeting of the American Society of Hematology at the Ernest N. Morial Convention Center in New Orleans, Louis
3Vote!
Eurekalert (Free subscription) | yesterday
( American Society of Hematology ) The American Society of Hematology, the world's largest professional association of blood specialists, expects more than 20,000 attendees at the 51st ASH Annual Meeting from Dec. 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans. The meeting will showcase the latest research and treatments for blood disorders.
+Vote!
Market Wire (Free subscription) | 30/11/2009
SOUTH SAN FRANCISCO, CA (MARKET WIRE) Cytokinetics, Incorporated (NASDAQ: CYTK) announced today that an abstract summarizing clinical trial data regarding SB-743921 is scheduled to be presented as a poster presentation at the 2009 American Society of Hematology (ASH) Annual Meeting and Exposition to be held December 5-8, 2009 at the Ernest N. Morial Convention Center in New Orleans,...
3Vote!
SeekingAlpha.com (Free subscription) | 30/11/2009
Michael Becker submits: The 51 st American Society of Hematology [ASH] Annual Meeting will take place December 5-8, 2009, at the Ernest N. Morial Convention Center in New Orleans, LA. This is the premier event for the hematology industry, attracting more than 20,000 hematologists and other health-care professionals. In this regard, Celgene Corporation ( CELG ) recently announced...
+Vote!
Medical News Today (Free subscription) | 26/11/2009
Gloucester Pharmaceuticals announced multiple presentations from clinical and preclinical studies of ISTODAX® (romidepsin) at the upcoming 51st American Society of Hematology (ASH) Annual Meeting being held in New Orleans, Louisiana, at the Ernest N. Morial Convention Center, December 5 - 8, 2009. ISTODAX, a novel histone deacetylase (HDAC) inhibitor, was recently approved...
+Vote!
Business Wire (Free subscription) | 24/11/2009
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Gloucester Pharmaceuticals today announced multiple presentations from clinical and preclinical studies of ISTODAX® (romidepsin) at the upcoming 51st American Society of Hematology (ASH) Annual Meeting being held in New Orleans, Louisiana, at the Ernest N. Morial Convention Center, December 5 – 8, 2009. ISTODAX, a novel histone deacetylase...